Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Viavi Solutions reported sharply higher revenue but swung to a loss as it executed major acquisitions and refinancing. Net revenue rose to $369.3 million for the quarter and $668.4 million for six months, driven largely by Network and Service Enablement and the addition of new businesses.
The company posted a quarterly net loss of $48.1 million and a six‑month net loss of $69.5 million, mainly due to a $38.7 million loss on extinguishing 2026 convertible notes and higher interest expense of $15.3 million for the quarter. Operating income declined despite stronger gross profit.
Viavi acquired Spirent’s high‑speed Ethernet, network security and channel emulation testing business for $399.3 million, adding $111.3 million of goodwill and $314.2 million of intangible assets. It now carries $600 million of Term Loan B debt and $250 million of new 0.625% convertible notes, lifting long‑term debt to $1,221.7 million and boosting cash and equivalents to $765.5 million.
Viavi Solutions Inc. disclosed a new restructuring plan alongside preliminary results for its fiscal second quarter ended December 27, 2025. The company furnished a press release with its preliminary quarterly results as an exhibit.
On January 23, 2026, Viavi approved a global restructuring plan aimed at improving operational efficiency, aligning its workforce with current business needs and strategic growth areas, and integrating recently acquired businesses. The plan includes a worldwide workforce reduction, facilities rationalization, and asset write-offs, with approximately 5% of the global workforce expected to be affected.
Viavi estimates total charges of about $32 million, including roughly $24 million of cash expenditures primarily for employee severance and related costs. Most charges are expected to be recognized by the end of June 2026, with the plan substantially completed by the end of calendar 2026. Upon completion, the company anticipates approximately $30 million in annualized cost savings, though actual amounts and timing may differ from these initial estimates.
Viavi Solutions Inc. entered into privately negotiated agreements to exchange $103.463 million aggregate principal amount of its 1.625% Convertible Senior Notes due 2026 for 7,871,043 shares of common stock at $17.88 per share with certain institutional holders. The exchange is expected to close on or about December 22, 2025, leaving approximately $49.037 million principal amount of these notes outstanding.
The company will not receive cash proceeds, because noteholders are swapping existing debt for equity. The shares issued in the exchange are expected to be offered in reliance on the Section 4(a)(2) exemption from registration under the Securities Act, based in part on representations made by the participating holders.
A director of Viavi Solutions Inc. reported selling 3,384 shares of common stock at $18.76 per share on December 10, 2025. The sale was executed under a pre-arranged Rule 10b5-1 stock trading plan dated September 10, 2025, which allows trades to follow preset instructions. After this transaction, the director beneficially owned 3,384 shares directly.
Viavi Solutions Inc. reported the results of its 2025 Annual Meeting of Stockholders held on November 12, 2025. Stockholders representing about 205.7 million shares, or roughly 92% of outstanding common stock on the record date, were present in person or by proxy. All nine director nominees received strong majority support and were elected to serve until the 2026 annual meeting.
Stockholders ratified the appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 and approved, on an advisory basis, the compensation of the company’s named executive officers. They also approved an amendment and restatement of the 2003 Equity Incentive Plan. In addition, stockholders approved amendments to the company’s Certificate of Incorporation to add an officer exculpation provision permitted under Delaware law, and the amended and restated charter became effective upon filing with the State of Delaware on November 13, 2025.
VIAVI Solutions (VIAV) reported a director equity award on a Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (RSUs) at a price of $0, representing the right to receive the same number of shares of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes that RSUs have no expiration date. Following the transaction, the reporting person held 14,369 derivative securities directly, each underlying one share of common stock.
VIAVI Solutions (VIAV) director reported a grant of 14,369 restricted stock units (RSUs) on 11/13/2025, according to a Form 4 filing. The units vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. Following the transaction, 14,369 derivative securities were beneficially owned, with ownership reported as direct.
Viavi Solutions (VIAV) director reported an equity award of 14,369 restricted stock units (RSUs) on 11/13/2025. Each RSU is tied to one share of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs.
Following the reported transaction, the director’s beneficially owned derivative securities total 14,369, held directly.
Viavi Solutions (VIAV) filed a Form 4 reporting a director’s grant of 14,369 restricted stock units (RSUs) on 11/13/2025 at a price of $0. Following the grant, the director beneficially owns 14,369 shares directly.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The RSUs have no expiration date.
Viavi Solutions (VIAV) disclosed a Form 4 showing a company director received 14,369 restricted stock units (RSUs) on November 13, 2025 at a price of $0.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs have no expiration date. Following the transaction, 14,369 derivative securities are beneficially owned, reported as direct ownership. Each RSU represents a right to receive one share of common stock upon vesting.